Disease & disorder
Okur-Chung neurodevelopmental syndrome
MONDO:0014893
Research intelligence
Directly mapped studies only · unique clinical trialsCurrent registry observations. Phase counts may overlap. Study start dates are not registry registration dates. Investigational interventions are not approved-treatment recommendations.
Medications under investigation
Verified disease and drug mappings that co-occur within the same study; not evidence of effectiveness.
Loading mapped interventions…
MONDO disease family
Loading verified ontology relationships…
Recruiting studies by city
Loading research-site locations…
Trial status
Loading…
Trial phase
Loading…
Study start year
Loading…
Investigated drug interventions
Loading…
Background context
Okur–Chung neurodevelopmental syndrome
Okur-Chung Neurodevelopmental Syndrome (OCNDS) is an ultra-rare neurodevelopmental syndrome first discovered in 2016. It is believed to occur in around 1 in 100,000 live births. OCNDS is caused by pathogenic variants in the CSNK2A1 gene.
Background only. Canonical identity remains MONDO; clinical-trial relationships come from ClinicalTrials.gov.Drugs being studied
Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.